BUY 100 CVS @ $86.90

“ENTRY CVS: Post-earnings high-conviction play — EPS surprise +16.29% and revenue surprise +5.84% meet the earnings-surprise override. Momentum is stabilizing with RSI rising to 52.78 and 1d price change positive, while analyst support is unanimous positive across Baird/Piper/Bernstein/Argus/BofA. Market context is constructive with SPY +1.28% and healthcare slightly green; at ~$77.30, 4% event stop near $74.21.”